Logo.png
Novel Therapeutic Approaches for Diffuse Large B-cell Lymphoma
February 03, 2021 20:15 ET | DelveInsight Business Research LLP
Los Angeles, USA , Feb. 03, 2021 (GLOBE NEWSWIRE) -- Novel Therapeutic Approaches for Diffuse Large B-cell Lymphoma The Diffuse Large B-cell Lymphoma treatment spectrum has expanded significantly in...
Logo.png
Artificial Lung Devices Pipeline Looks Promising, a Positive Push to the Market Size Growth in the Future, estimates DelveInsight
February 03, 2021 03:00 ET | DelveInsight Business Research LLP
Los Angeles, USA, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Artificial Lung Devices Pipeline Looks Promising, a Positive Push to the Market Size Growth in the Future, estimates DelveInsight With 20+ key...
Logo.png
Advanced Pancreatic Cancer Pipeline Therapeutics and Analysis, 2021
February 01, 2021 20:00 ET | DelveInsight Business Research LLP
Las Vegas, USA, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Advanced Pancreatic Cancer Pipeline Therapeutics and Analysis, 2021 ERYtech Pharma, GlaxoSmithKline, Galera Therapeutics, Propanc and several...
Logo.png
Non-Muscle Invasive Bladder Cancer Pipeline Analysis Shows Tremendous Growth Opportunities for the Coming Years
January 27, 2021 20:30 ET | DelveInsight Business Research LLP
Los Angeles, USA, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Non-Muscle Invasive Bladder Cancer Pipeline Analysis Shows Tremendous Growth Opportunities for the Coming Years With over 30+ players proactively...
Logo.png
Global Exosome Pipeline Report 2021: Insights on 50+ Companies and 50+ Pipeline Drugs | DelveInsight
January 25, 2021 20:00 ET | DelveInsight Business Research LLP
Los Angeles, USA, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Global Exosome Pipeline Report 2021: Insights on 50+ Companies and 50+ Pipeline Drugs | DelveInsight  Exosomes Pipeline is robust and possesses...
Logo.png
Adalimumab Biosimilar Landscape Report Provides an Analysis of 35+ Companies along with Updated 45+ Marketed and Pipeline Drugs | DelveInsight
January 19, 2021 20:00 ET | DelveInsight Business Research LLP
Los Angeles, USA, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Adalimumab Biosimilar Landscape Report Provides an Analysis of 35+ Companies along with Updated 45+ Marketed and Pipeline Drugs | DelveInsight  ...
Logo.png
Implantable Cardiac Monitors Market Expected To Rise By A CAGR Of 4.4% By 2025
January 18, 2021 20:00 ET | DelveInsight Business Research LLP
Los Angeles, USA, Jan. 18, 2021 (GLOBE NEWSWIRE) -- Implantable Cardiac Monitors Market Expected To Rise By A CAGR Of 4.4% By 2025The steady growth of the Implantable Cardiac monitors (ICM) market...
Logo.png
Diabetic Peripheral Neuropathy Pipeline Assessment 2020: Therapeutic Analysis Report Featuring 20+ Companies & 15+ Drug Profiles
January 14, 2021 18:00 ET | DelveInsight Business Research LLP
Los Angeles, USA, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Diabetic Peripheral Neuropathy Pipeline Assessment 2020: Therapeutic Analysis Report Featuring 20+ Companies & 15+ Drug Profiles  Diabetic...
Logo.png
Nonalcoholic Steatohepatitis Drug Pipeline Analysis Review, 2020
January 13, 2021 20:00 ET | DelveInsight Business Research LLP
Los Angeles, USA , Jan. 13, 2021 (GLOBE NEWSWIRE) -- Nonalcoholic Steatohepatitis Drug Pipeline Analysis Review, 2020  NASH Drug Pipeline Shows Promise as 95+ companies are working for...
Logo.png
Multiple System Atrophy Pipeline Expected to Offer Myriad of Novel Therapies in the Next Decade
January 13, 2021 18:30 ET | DelveInsight Business Research LLP
Los Angeles, USA, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Multiple System Atrophy Pipeline Expected to Offer Myriad of Novel Therapies in the Next Decade Multiple System Atrophy Clinical Trial Analysis...